Clinical Trials Register

Trials with a EudraCT protocol (102)
Paediatric studies in scope of Art45 of the Paediatric Regulation (3)

102 result(s) found for: Abdominal discomfort. Displaying page 5 of 6.

EudraCT Number: 2020-000501-93

Sponsor Protocol Number: BCX9930-201

Start Date*: 2020-09-29

Sponsor Name:BioCryst Pharmaceuticals Inc

Full Title: A Phase 2, Open-Label Study to Evaluate the Long-term Safety of Oral BCX9930 in Subjects with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Medical condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004857	10055629	Paroxysmal nocturnal hemoglobinuria	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) AT (Completed) DK (Prematurely Ended) IT (Completed)

Trial results: View results

EudraCT Number: 2008-000214-71

Sponsor Protocol Number: NAK-03

Start Date*: 2008-07-01

Sponsor Name:Laboratorios Menarini S.A. (Menarini Group)

Full Title: Double blind, randomized, placebo-controlled, parallel group study to evaluate the effect of a 4-week treatment with oral doses of MEN15596 in irritable bowel syndrome.

Medical condition: Irritable Bowel Syndrome.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10023003	Irritable bowel syndrome	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) ES (Completed) SK (Completed) LV (Completed) DE (Completed) DK (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2019-002871-32

Sponsor Protocol Number: D3255C00001

Start Date*: 2020-02-05

Sponsor Name:AstraZeneca AB

Full Title: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis (MESSINA)

Medical condition: Eosinophilic Esophagitis (EoE)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004856	10064220	Eosinophilic esophagitis	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) DE (Prematurely Ended) GB (GB - no longer in EU/EEA) FR (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2018-003558-26

Sponsor Protocol Number: ABX464-103

Start Date*: 2019-12-10

Sponsor Name:ABIVAX

Full Title: A randomized, double blind, placebo controlled, parallel group, multiple dose, induction study to evaluate the safety, tolerability and optimal dose of ABX464 compared with placebo in patients with...

Medical condition: Moderate to Severe Ulcerative Colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004856	10066678	Acute ulcerative colitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) SI (Completed) CZ (Completed) DE (Completed) SK (Completed) HU (Completed) PL (Completed) BE (Completed) GB (GB - no longer in EU/EEA) IT (Completed)

Trial results: View results

EudraCT Number: 2011-004812-40

Sponsor Protocol Number: D2211C00001

Start Date*: 2012-01-26

Sponsor Name:AstraZeneca AB

Full Title: A phase IIa, randomised, double-blind, placebo-controlled, parallel-arm, multicenter study to evaluate the efficacy and safety of tralokinumab (CAT-354), a recombinant human monoclonal antibody dir...

Medical condition: Ulcerative Colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004856	10045365	Ulcerative colitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) NL (Prematurely Ended) CZ (Completed) IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2020-003288-24

Sponsor Protocol Number: GRN163LMYF3001

Start Date*: 2021-05-10

Sponsor Name:Geron Corporation

Full Title: A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/...

Medical condition: Myelofibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028537	Myelofibrosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) BE (Trial now transitioned) DK (Trial now transitioned) FR (Trial now transitioned) HU (Trial now transitioned) AT (Trial now transitioned) PT (Trial now transitioned) BG (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2010-019521-34

Sponsor Protocol Number: A0081180

Start Date*: 2010-11-03

Sponsor Name:Pfizer Inc.

Full Title: A 15 WEEK, RANDOMIZED, DOUBLE BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, FLEXIBLE-DOSE, SAFETY AND EFFICACY STUDY OF PREGABALIN IN ADOLESCENTS (12-17 YEARS OLD) WITH FIBROMYALGIA

Medical condition: Fibromyalgia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10028395 - Musculoskeletal and connective tissue disorders	10048439	Fibromyalgia	PT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2010-021349-36

Sponsor Protocol Number: VRP100419 (CHDR1018)

Start Date*: 2010-11-08

Sponsor Name:Verona Pharma plc

Full Title: Randomised, Double-Blind, Placebo-Controlled Evaluation of the Safety and Duration of Action of 2 Single Inhaled Doses, 0.036 mg/kg (12X) and 0.072 mg/kg (24X), of RPL554, a Dual PDE 3/4 Inhibitor,...

Medical condition: Allergic Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10001705	Allergic asthma	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2011-001698-22

Sponsor Protocol Number: VRP110330

Start Date*: 2011-04-29

Sponsor Name:Verona Pharma plc

Full Title: EVALUATION OF THE EFFICACY AND SAFETY OF 6 REPEATED DAILY DOSES OF NEBULISED RPL554 0.018 mg/kg (6X) IN ALLERGIC ASTHMATICS

Medical condition: Allergic asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10038738 - Respiratory, thoracic and mediastinal disorders	10001705	Allergic asthma	LLT

Population Age: Adults

Gender: Male

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2012-003052-37

Sponsor Protocol Number: NER1006-01/2012(OPT)

Start Date*: 2012-10-17

Sponsor Name:Norgine Ltd

Full Title: Pharmacodynamic and clinical evaluation of dose and taste-optimised low volume PEG-based bowel cleansing solutions using the split-dosing intake regimen in healthy subjects and in subjects undergoi...

Medical condition: Bowel cleansing prior to colonoscopy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10042613 - Surgical and medical procedures	10066943	Bowel preparation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2014-001048-40

Sponsor Protocol Number: B1371013

Start Date*: 2015-02-10

Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, 10017

Full Title: A phase 2, double-blind, randomized safety and efficacy study of Glasdegib (PF-04449913) versus placebo in patients with Myelofibrosis previously treated with ruxolitinib.

Medical condition: Myelofibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028537	Myelofibrosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) ES (Completed) AT (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2014-004425-41

Sponsor Protocol Number: ESN364-UF-02

Start Date*: 2015-01-21

Sponsor Name:Euroscreen S.A

Full Title: A Phase IIa, Double-Blind, Placebo-Controlled, Study of ESN364 Administered for 12 Weeks to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Women Presenting With ...

Medical condition: Uterine Fibroids

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004864	10046784	Uterine fibroids	LLT

Population Age: Adults

Gender: Female

Trial protocol: BE (Completed) DE (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2008-008135-28

Sponsor Protocol Number: 01-281108

Start Date*: 2009-04-16

Sponsor Name:Hull and East Yorkshire NHS Hospitals Trust

Full Title: Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure

Medical condition: We will investigate the effect of sildenafil on pulmonary artery pressure in Heart failure patients (impaired heart function). Patients will be recruited from the Heart Failure clinic at Castle Hil...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10002034	Anaemia	LLT
	9.1		10040756	Sinusitis NOS	LLT
	9.1		10016807	Fluid retention	LLT
	9.1		10022437	Insomnia	LLT
	9.1		10016998	Forehead headache	LLT
	9.1		10010108	Common migraine	LLT
	9.1		10002855	Anxiety	LLT
	9.1		10044565	Tremor	LLT
	9.1		10033987	Paresthesia	LLT
	9.1		10006790	Burning sensation NOS	LLT
	9.1		10020937	Hypoaesthesia	LLT
	9.1		10007882	Cellulitis	LLT
	9.1		10022000	Influenza	LLT
	9.1		10038870	Retinal hemorrhage	LLT
	9.1		10047544	Visual disturbance NOS	LLT
	9.1		10047513	Vision blurred	LLT
	9.1		10034960	Photophobia	LLT
	9.1		10008795	Chromatopsia	LLT
	9.1		10051819	Cyanopsia	LLT
	9.1		10015910	Eye blood shot	LLT
	9.1		10015946	Eye irritation	LLT
	9.1		10038189	Red eye	LLT
	9.1		10047531	Visual acuity reduced	LLT
	9.1		10013036	Diplopia	LLT
	9.1		10000173	Abnormal sensation in eye	LLT
	9.1		10047340	Vertigo	LLT
	9.1		10065027	Sudden deafness	LLT
	9.1		10016825	Flushing	LLT
	9.1		10006461	Bronchitis NOS	LLT
	9.1		10015090	Epistaxis	LLT
	9.1		10039092	Rhinitis NOS	LLT
	9.1		10011224	Cough	LLT
	9.1		10028735	Nasal congestion	LLT
	9.1		10012735	Diarrhoea	LLT
	9.1		10013946	Dyspepsia	LLT
	9.1		10017869	Gastritis NOS	LLT
	9.1		10017888	Gastroenteritis	LLT
	9.1		10017885	Gastrooesophageal reflux disease	LLT
	9.1		10019022	Haemorrhoids	LLT
	9.1		10000060	Abdominal distension	LLT
	9.1		10013781	Dry mouth	LLT
	9.1		10001760	Alopecia	LLT
	9.1		10015150	Erythema	LLT
	9.1		10029410	Night sweats	LLT
	9.1		10040913	Skin rash	LLT
	9.1		10028411	Myalgia	LLT
	9.1		10003988	Back pain	LLT
	9.1		10018800	Gynaecomastia	LLT
	9.1		10036661	Priapism	LLT
	9.1		10052791	Erection increased (excl priapism)	LLT
	9.1		10037660	Pyrexia	LLT
	9.1		10042438	Sudden hearing loss, unspecified	LLT
	9.1		10033425	Pain in extremity	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2020-000236-22

Sponsor Protocol Number: Study_protocol_CODEX-P_ver2_1

Start Date*: 2020-12-16

Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN)

Full Title: COPD EXacerbation and Pulmonary hypertension Trial - The effect of Sildenafil treatment to patients with COPD exacerbation and pulmonary hypertension

Medical condition: This study will investigate treatment of patients with chronic obstructive pulmonary disease (COPD), who experience frequent exacerbations (AECOPD). Only patients with a minimum of 2 moderate AECOP...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004854	10019203	Head spinning	LLT
	20.1	100000004852	10033405	Pain head	LLT
	20.0	100000004852	10019218	Headache NOS	LLT
	20.1	100000004856	10000460	Acid dyspepsia	LLT
	22.1	100000004856	10013947	Dyspepsia aggravated	LLT
	20.0	100000004856	10013948	Dyspepsia and other specified disorders of function of stomach	LLT
	21.1	100000004856	10019328	Heartburn-like dyspepsia	LLT
	20.1	100000004856	10064536	Functional dyspepsia	LLT
	23.1	100000004856	10012727	Diarrhea	LLT
	20.0	100000004859	10023222	Joint pain	LLT
	21.0	100000004859	10025012	Lumbo-sacral pain	LLT
	21.1	100000004859	10028322	Muscle pain	LLT
	20.0	100000004856	10033394	Pain epigastric	LLT
	21.1	100000004866	10016046	Facial flushing	LLT
	20.0	100000004853	10013614	Double vision	LLT
	21.0	100000004848	10005604	Blood in urine	LLT
	20.0	100000004872	10018801	Gynecomastia	LLT
	20.0	100000004872	10060603	Hematospermia	LLT
	20.0	100000004851	10002272	Anemia	LLT
	22.1	100000004853	10034961	Photophobia aggravated	LLT
	20.0	100000004871	10023139	Jaundice NOS	LLT
	20.0	100000004853	10030042	Ocular hyperemia	LLT
	20.1	100000004853	10051304	Retinal bleeding	LLT
	20.1	100000004853	10005889	Blurry vision	LLT
	20.1	100000004856	10046272	Upper abdominal pain	LLT
	20.0	100000004856	10038263	Reflux oesophagitis	LLT
	20.0	100000004856	10047706	Vomiting NOS	LLT
	20.0	100000004867	10016558	Fever	LLT
	21.1	100000004862	10024969	Lower respiratory tract infection NOS	LLT
	20.0	100000004859	10048317	Myalgia aggravated	LLT
	21.1	100000004859	10003990	Back pain (without radiation)	LLT
	20.1	100000004852	10020922	Hypesthesia	LLT
	20.0	100000004852	10027605	Migraine NOS	LLT
	21.1	100000004852	10044572	Tremor limb	LLT
	20.1	100000004852	10044570	Tremor finger	LLT
	20.0	100000004873	10002856	Anxiety attack	LLT
	20.0	100000004873	10022442	Insomnia NOS	LLT
	20.0	100000004855	10011232	Coughing	LLT
	20.0	100000004862	10040756	Sinusitis NOS	LLT
	20.0	100000004867	10014210	Edema	LLT
	20.0	100000004867	10014211	Edema (NOS)	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2017-000937-30

Sponsor Protocol Number: ABX464-101

Start Date*: 2017-09-29

Sponsor Name:ABIVAX

Full Title: A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in subjects with Moderate to Severe Active Ulcerative Colitis who have failed or are intolerant to im...

Medical condition: Moderate to severe Ulcerative Colitis.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004856	10066678	Acute ulcerative colitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) HU (Completed) FR (Completed) DE (Completed) PL (Completed) ES (Prematurely Ended) AT (Completed)

Trial results: View results

EudraCT Number: 2016-004486-37

Sponsor Protocol Number: 59812

Start Date*: 2017-09-19

Sponsor Name:University Medical Centre Utrecht

Full Title: FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment

Medical condition: Acute febrile urinary tract infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000017512	10046574	Urinary tract infection NOS	LLT
	20.0	100000017512	10046576	Urinary tract infection, site not specified	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-001955-38

Sponsor Protocol Number: LIN-MD-66

Start Date*: 2021-05-10

Sponsor Name:Allergan Ltd

Full Title: A Phase 3, Open-label, Long-term Safety Study of Oral Linaclotide Administered to Pediatric Participants with Functional Constipation (FC) or Irritable Bowel Syndrome with Constipation (IBS-C)

Medical condition: Functional Constipation (FC) Irritable bowel syndrome with constipation (IBS-C)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10017947 - Gastrointestinal disorders	10010774	Constipation	PT
	20.1	10017947 - Gastrointestinal disorders	10066868	Constipation predominant irritable bowel syndrome	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: HU (Prematurely Ended) BG (Completed)

Trial results: (No results available)

EudraCT Number: 2006-003935-56

Sponsor Protocol Number: TMC-CAN-05-03

Start Date*: 2006-11-24

Sponsor Name:The Medicines Company

Full Title: A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention

Medical condition: Subjects with coronary atherosclerosis (excluding ST segment-elevation MI [STEMI]) who require PCI (with or without stent).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10011093	Coronary atherosclerosis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed) ES (Completed) CZ (Prematurely Ended) LT (Completed) SK (Completed) DE (Prematurely Ended) IT (Completed)

Trial results: View results

EudraCT Number: 2010-020484-20

Sponsor Protocol Number: 20621-200

Start Date*: 2011-07-05

Sponsor Name:ViroPharma Incorporated

Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF VP 20621 FOR PREVENTION OF RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) IN AD...

Medical condition: Clostridium difficile infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004862	10054236	Clostridium difficile infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) DE (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2011-006319-69

Sponsor Protocol Number: 1.0

Start Date*: 2012-10-25

Sponsor Name:Pedro Villarejo Campos(Hospital Universitario Ciudad Real)

Full Title: Closed abdomen hyperthermic intraperitoneal chemotherapy with paclitaxel for advanced epithelial ovarian cancer

Medical condition: ovarian cancer (II,III,IV FIGO staging and tumoral recurrence)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10005329 - Blood and lymphatic system disorders	10028584	Myelosuppression	LLT
	14.1	10007541 - Cardiac disorders	10006093	Bradycardia	PT
	14.1	10017947 - Gastrointestinal disorders	10028813	Nausea	PT
	14.1	10017947 - Gastrointestinal disorders	10012727	Diarrhea	LLT
	14.1	10017947 - Gastrointestinal disorders	10047700	Vomiting	PT
	14.1	10018065 - General disorders and administration site conditions	10028127	Mucositis	LLT
	14.1	10028395 - Musculoskeletal and connective tissue disorders	10003239	Arthralgia	PT
	14.1	10040785 - Skin and subcutaneous tissue disorders	10001760	Alopecia	PT
	14.1	10021881 - Infections and infestations	10046544	Urinary infection	LLT
	14.1	10047065 - Vascular disorders	10021097	Hypotension	PT
	14.1	10028395 - Musculoskeletal and connective tissue disorders	10028411	Myalgia	PT
	14.1	10021881 - Infections and infestations	10038700	Respiratory infection	LLT
	14.1	10029205 - Nervous system disorders	10034610	Peripheral neuropathy NOS	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Abdominal discomfort